TrialBritish journal of cancer2004

Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies.

J J Body et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.